GlassScriptPhysician profile
Elizabeth Murphy
NPI 1003251513
$4,425.10
in general payments reported to CMS, 2019-2025
22 companies · $359 in 2025
The $359 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,153 · 2020: $1,194 · 2021: $496 · 2022: $588 · 2023: $324 · 2024: $312 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $995.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $994.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $1,479.16 | 2019-2020 | |
| Allergan, INC. | $641.78 | 2019-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $419.27 | 2019-2025 | Amo Phaco Needle, Tecnis Simplicity, Catalys System |
| Alcon Vision LLC | $330.82 | 2019-2025 | Clareon, Clareon Panoptix Pro, Tryptyr |
| Sun Pharmaceutical Industries INC. | $325.32 | 2021-2025 | Cequa |
| Abbvie INC. | $266.84 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $201.27 | 2022-2025 | Vyzulta, Xiidra, Miebo |
| Novartis Pharmaceuticals Corporation | $177.46 | 2019-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $157.18 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $66.05 | 2019-2021 | |
| Oyster Point Pharma, INC. | $60.30 | 2022 | |
| Rxsight INC | $42.66 | 2024-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Biotissue Holdings INC. | $41.87 | 2022 | |
| Akorn, INC. | $41.36 | 2020 | |
| Dompe US, INC. | $27.35 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $24.98 | 2023 | Tearcare System |
| Akorn Operating Company LLC | $24.60 | 2021 | |
| Thea Pharma INC. | $24.07 | 2025 | Iyuzeh |
| Merz Pharmaceuticals, LLC | $19.42 | 2022 | |
| Alcon Research LLC | $18.82 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $17.78 | 2023 | Acuvue |
| Shire North American Group INC | $16.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.